Hengehold Capital Management LLC Acquires 19,308 Shares of Procter & Gamble Company (The) $PG

Hengehold Capital Management LLC boosted its stake in Procter & Gamble Company (The) (NYSE:PG) by 4.7% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 426,481 shares of the company’s stock after buying an additional 19,308 shares during the period. Procter & Gamble accounts for 5.1% of Hengehold Capital Management LLC’s portfolio, making the stock its 2nd biggest holding. Hengehold Capital Management LLC’s holdings in Procter & Gamble were worth $61,119,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in shares of Procter & Gamble by 0.6% in the third quarter. Vanguard Group Inc. now owns 234,630,605 shares of the company’s stock valued at $36,050,992,000 after acquiring an additional 1,419,322 shares in the last quarter. State Street Corp raised its holdings in Procter & Gamble by 0.4% during the third quarter. State Street Corp now owns 100,634,824 shares of the company’s stock worth $15,462,541,000 after purchasing an additional 370,872 shares in the last quarter. Franklin Resources Inc. lifted its position in Procter & Gamble by 8.3% in the third quarter. Franklin Resources Inc. now owns 22,850,345 shares of the company’s stock worth $3,510,955,000 after purchasing an additional 1,752,481 shares during the period. Legal & General Group Plc boosted its stake in Procter & Gamble by 1.2% during the 3rd quarter. Legal & General Group Plc now owns 16,556,061 shares of the company’s stock valued at $2,543,839,000 after purchasing an additional 189,968 shares in the last quarter. Finally, Invesco Ltd. increased its position in shares of Procter & Gamble by 21.4% during the 2nd quarter. Invesco Ltd. now owns 16,374,499 shares of the company’s stock valued at $2,608,785,000 after purchasing an additional 2,880,895 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Price Performance

Shares of PG opened at $144.44 on Wednesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72. The firm has a market cap of $335.67 billion, a PE ratio of 21.40, a PEG ratio of 4.84 and a beta of 0.37. The firm’s 50 day moving average price is $153.88 and its 200 day moving average price is $149.88. Procter & Gamble Company has a twelve month low of $137.62 and a twelve month high of $174.80.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, January 23rd. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The firm had revenue of $22.21 billion for the quarter, compared to the consensus estimate of $22.36 billion. During the same quarter last year, the firm posted $1.88 EPS. The business’s quarterly revenue was up 1.5% on a year-over-year basis. As a group, research analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, February 17th. Shareholders of record on Friday, January 23rd were paid a dividend of $1.0568 per share. The ex-dividend date was Friday, January 23rd. This represents a $4.23 dividend on an annualized basis and a yield of 2.9%. Procter & Gamble’s payout ratio is currently 62.52%.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, insider Susan Street Whaley sold 1,809 shares of the company’s stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $159.46, for a total value of $288,463.14. Following the sale, the insider directly owned 30,215 shares in the company, valued at $4,818,083.90. This represents a 5.65% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Chairman Jon R. Moeller sold 162,232 shares of the stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the sale, the chairman owned 319,385 shares of the company’s stock, valued at $51,884,093.25. This trade represents a 33.68% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 348,618 shares of company stock worth $55,462,643. 0.20% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on PG. Erste Group Bank lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Tuesday, March 24th. Rothschild & Co Redburn upped their price target on Procter & Gamble from $155.00 to $157.00 and gave the company a “neutral” rating in a report on Friday, January 23rd. Dbs Bank raised Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Friday, January 23rd. TD Cowen lowered Procter & Gamble from a “buy” rating to a “hold” rating and boosted their target price for the stock from $150.00 to $156.00 in a research report on Tuesday, January 27th. Finally, Barclays set a $155.00 target price on Procter & Gamble in a report on Friday, January 16th. Twelve equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and an average target price of $167.83.

Key Procter & Gamble News

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: OLAY peptide research — New clinical and mechanistic data presented for OLAY highlight proprietary peptide technology and cell‑adhesion targets that P&G plans to move rapidly into formulations; successful commercialization could bolster pricing power and organic growth for a core beauty brand. OLAY Peptide Research Puts New Spotlight On Procter And Gamble Valuation
• Positive Sentiment: Analysts remain constructive in places — coverage notes that P&G can fare better than peers amid sluggish consumer sentiment, supporting the view of PG as a relatively defensive consumer staples holding. Analysts Constructive on The Procter & Gamble (PG) Amid Sluggish Consumer Sentiment
• Neutral Sentiment: Recent trading strength — PG ticked higher while the broader market fell on 3/30, showing relative strength that may reflect defensive demand; however this was a short‑term move rather than new fundamental news. Procter & Gamble (PG) Ascends While Market Falls: Some Facts to Note
• Neutral Sentiment: Q4 results mixed — Q4 EPS slightly beat estimates (+$0.02) while revenue marginally missed; steady margins and cash flow help the case for the dividend and buybacks, but top‑line softness tempers upside. (Earnings detail from recent company report.)
• Neutral Sentiment: Deutsche Bank trimmed its price target (from $171 to $162) but kept a Hold — this narrows upside but is not a sell signal; investors should weigh this against other analyst views. Deutsche Bank Lowers Price Target on PG
• Neutral Sentiment: Unrelated retailer weakness — a separate report on RH’s weak quarter is unlikely to directly affect PG but signals broader discretionary‑spending challenges in retail. RH (RH) Lags Q4 Earnings and Revenue Estimates
• Negative Sentiment: TD Cowen cut its price target to $142 (from $156) and kept a Hold, citing oil‑linked input cost inflation tied to the Iran war that it believes P&G cannot fully absorb — this is the main near‑term headwind pressuring the stock. Wall Street Downgrades Procter & Gamble Amid Iran War Cost Pressures and More

About Procter & Gamble

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.